Abstract
Nisoldipine is a second-generation dihydropyridine calcium antagonist structurally related to nifedipine and used in the treatment of stable angina and arterial hypertension. It is also under investigation for the treatment of left ventricular dysfunction. It was first developed as an immediate release tablet, but this formulation was not considered optimal for once-daily administration because of the variable results obtained at peak and trough in clinical studies. Consequently, nisoldipine coat core (CC) was developed with the aim of optimizing the drug’s time-effect profile over the 24-h dosing interval. The in vitro release pattern classifies this tablet as an “extended release” formulation according to European Community guidelines. The present article outlines the pharmacokinetic and pharmacodynamic profiles of nisoldipine CC, as obtained from recent clinical studies. (Am J Cardiol 1995; 75:41 E-45E)
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Lasseter KC, Shamblen EC, Lettieri J, Kml G, Taylor RJ, Fein SH (1987) Dose-proportional pharmacokinetics of nisoldipine in healthy volunteers. Clin Pharmacol Ther 41: 234
Edgar B, Bailey D, Bergstrand R, Johnsson G, Regardh CG (1992) Acute effects of drinking grapefruit juice on the pharmacokinetics and dynamics of felodipineand its potential clinical relevance. Eur J Pharmacol 42: 313–317
Bolaert J, Valcke Y, Dammekens H, Devries G, Schurgers M, Daneels R, Bogaert MG (1988) Pharmacokinetics of nisoldipine in renal dysfunction. Eur J Clin Pharmacol 34: 207–209
Breimer DD, Lodewijks MTM, Van Brummelen P, Van Harten J, Wilson JPH (1986) Pharmacokinetics and haemodynanic effects of nisoldipine in patients with liver cirrhosis. BrJ Pharmacol 89 (Suppl): 482
Joeres R, Ahr G, Hofstetter G, Klinker H, Richter E (1987) Steady state pharmacokinetics of nisoldipine in patients with liver disease. In: Hugenholtz PG, Meyer J, eds. Nisoldipine 1987. Berlin-Heidelberg: Springer-Verlag 80–84
Van Harten J, Van Brummelen P, Van Wilson JHP, Lodewijks MTM, Breimer DD (1988) Nisoldipine: kinetics and effects on blood pressure and heart rate in patients with liver cirrhosis after intravenous and oral administration. Eur J Clin Pharmacol 34: 387–394
Elliott HL, Meredith PA, McNally C, Reid JL (1991) The interactions between nisoldipine and two ß-adrenoceptor antagonists, atenolol and propranolol. Br J Clin Pharmacol 32: 279–385
Levine MAH, Ogilive RI, Leenen FHH (1988) Pharmacokinetic and pharmacodynamic interactions between nisoldipine and propranolol. Clin Pharmacol 7her 43: 39–48
Shaw-Stiffel TA, Browning FM, Holliwell DL, Ogilvie RI, Leenen FHH (1989) Pharmacokinetic and pharmacodynamic interaction between nisoldipine and propranolol during chronic dosing. Clin Invest Med 12 (Suppl 4): 314
Kirch W, Stenzel J, Dylewicz P, Hutt HJ, Santos SR, Ohenhaus EE (1986) Influence of nisoldipine on haemodynamic effects and plasma levels of digoxine. Br J Clin Pharmacol 22: 155–159
Kuhlmann J, Ziegler R, Wingender W, Ramsch KD, Ahr G (1986) Beeinflussen Nisoldipine, Nitrendipie and Nimodipin die Pharmakokinetik and Wirksamkeit von Herzglykosiden? Z Kardiol 75 (Suppl 4): 78
Van Harten J, Van Brummelen P, Danhof M, Lodewijks MTM, Breimer DD (1986) Pharmacokinetics and haemodynamic effects of nisoldipine and its interaction with cimetidine in healthy volunteers. Acta Pharmacol Toxicol 59 (Suppl 5): 314
Van Harten J, Van Brummelen P, Danhof M, Lodewijks MTM, Breimer DD (1988) Pharmacokinetics and haemodynamic effects of nisoldipine and its interaction with cimetidine. Clin Pharmacol Ther 43: 332–341
Godfraind T, Egleme C, Finet M, Jaumin P (1987) The action of nifedipine and nisoldipine on the contractile activity of human coronary arteries and human cardiac tissue in vitro. Pharm Toxicol 61: 79–84
Godfraind T (1994) Cardioselectivity of calcium antagonists Cardiovasc Drugs Ther 8: 353–364
Friedel HA, Sorkin EM (1988) Nisoldipine–a preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficiency in the treatment of anginal pectoris, hypertension and related cardiovascular disorders. Drug 36: 682–731
The Defiant Research Group (1992) Improved diastolic function with the calcium antagonist nisoldipine (coat-core) in patients with post myocardial infarction: results of the DEFIANT Study. Eur Heart J 13: 1496–1505
Pouleur H, Van Eyll C, Gurne O, Rousseau MF (1992) Analysis of the mechanisms underlying the changes in left ventricular filling dynamics during oral nisoldipine therapy in patients with anterior myocardial infarction. Eur Heart J 13: 952–959
Dymond DS, Caplin JL, O’Keefe JC, Banim S (1987) Effects of nisoldipine on left ventricular function during exercise or cold pressor stress. Eur Heart J 8 (Suppl K): 27–33
Mindejahn KP, Hanrath P, Thier W, Bleifeld W (1983) Hemodynamic effect of nisoldipine in chronic congestive heart failure. (Abstr.) Eur Heart J 4 (Suppl E): 26
Barjon JN, Rouleau JL, Bichet D, Juneau C, De Champlain J (1987) Chronic renal and neurohumoral effects of the calcium entry blocker nisoldipine in patients with congestive heart failure. J Am Coll Cardiol 9: 622–630
Rousseau MF, Vincent MF, Van Hoof F, Van Den Berghe G, Charlier AA, Pouleur H (1984) Effects of nicardipine and nisoldipine on myocardial metabolism, coronary blood flow and oxygen supply in angina pectoris. Am J Cardiol 54: 1189–1194
Lewis BS, Schefer A, Merdier A, Flugelman M, Hardoff R, Halon DA (1987) Acute effects of intravenous nisoldipine on hemodynamics and left ventricular function in cardiac failure. In: Hugenholtz PG, Meyer J, eds. Nisoldipine 1987. Berlin-Heidelberg. Springer-Verlag, 315–323
Serruys PW, Suryapranata H, Planellas J, Wijns W, Vanhaleweyk GLJ, Soward A, Jaski BE, Hugenholtz PG (1985) Acute effects of intravenous nisoldipine on left ventricular function and coronary hemodynamics. Am J Cardiol 56: 140–146
Meredith PA, Pasanisi F, Elliott HL, Reid JL (1985) The effect of nisoldipine on apparent liver blood flow and effective renal plasma flow. Br J Clin Pharmacol 20: 235–237
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Zannad, F. (1999). Clinical Pharmacology of Nisoldipine Coat Core. In: Rousseau, M.F. (eds) Nisoldipine Coat-Core. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60220-7_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-60220-7_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-66049-1
Online ISBN: 978-3-642-60220-7
eBook Packages: Springer Book Archive